GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $65,306,000 | +15.9% | 2,044,000 | +25.7% | 1.18% | +29.4% |
| Q1 2022 | $56,345,000 | +379.1% | 1,626,600 | +425.6% | 0.91% | +543.7% |
| Q3 2018 | $11,761,000 | -41.8% | 309,500 | -30.8% | 0.14% | -41.1% |
| Q2 2018 | $20,217,000 | -71.5% | 447,275 | -69.5% | 0.24% | -72.6% |
| Q1 2018 | $70,833,000 | -16.6% | 1,466,530 | -32.0% | 0.88% | -18.2% |
| Q4 2017 | $84,907,000 | +14.2% | 2,157,730 | -9.9% | 1.07% | +51.3% |
| Q3 2017 | $74,322,000 | +25.1% | 2,393,635 | +10.2% | 0.71% | +14.0% |
| Q2 2017 | $59,402,000 | +48.6% | 2,171,935 | +100.3% | 0.62% | +37.5% |
| Q1 2017 | $39,964,000 | – | 1,084,500 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |